BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 60 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,000 | -12.5% | 2,100 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -89.9% | 2,100 | -89.8% | 0.00% | – |
| Q1 2021 | $79,000 | -17.7% | 20,678 | -2.7% | 0.00% | – |
| Q4 2020 | $96,000 | -63.8% | 21,249 | +35.5% | 0.00% | – |
| Q3 2020 | $265,000 | +73.2% | 15,683 | +15.0% | 0.00% | – |
| Q2 2020 | $153,000 | +920.0% | 13,640 | +286.8% | 0.00% | – |
| Q4 2019 | $15,000 | -84.0% | 3,526 | -88.2% | 0.00% | – |
| Q1 2018 | $94,000 | -75.6% | 29,912 | -69.7% | 0.00% | – |
| Q4 2017 | $386,000 | +310.6% | 98,590 | +330.0% | 0.00% | – |
| Q3 2017 | $94,000 | – | 22,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weaver Consulting Group | 130,000 | $437,000 | 0.21% |
| Ikarian Capital, LLC | 304,161 | $1,022,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 265,000 | $890,000 | 0.12% |
| S.C. Financial Services, Inc. | 15,285 | $51,000 | 0.06% |
| JMAC ENTERPRISES LLC | 45,430 | $153,000 | 0.04% |
| CFO4Life Group, LLC | 12,000 | $40,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 10,839 | $1,329,000 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 29,186 | $98,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 190,403 | $640,000 | 0.00% |